CSIMarket Company Name, Ticker, Competitors, else..


Cardiff Oncology Inc   (NASDAQ: CRDF)
Other Ticker:  
 

Cardiff Oncology Inc

CRDF's Fundamental analysis



Cardiff Oncology Inc 's sales fell by -90.36 % in the first quarter of 2025 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 11.44 %

Cardiff Oncology Inc net loss increased from $-10 millions, to $-13 millions in first quarter of 2025,

• More on CRDF's Growth


Cardiff Oncology Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 32.67 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 406.45.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.84.


• More on CRDF's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 13,656
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 0.78
 Tangible Book Value (Per Share $) 1.07

Cardiff Oncology Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 32.67 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 406.45.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.84.

Cardiff Oncology Inc Price to Book Ratio is at 2.51 higher than Industry Avg. of -61774.74, and higher than S&P 500 Avg. of 0.01

• More on CRDF's Valuation

•  Market Capitalization (Millions $) 178
•  Shares Outstanding (Millions) 67
•  Employees 32
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) -49
•  Cash Flow (TTM) (Millions $) 5
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 13,656
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 0.78
•  Tangible Book Value (Per Share $) 1.07

•  Market Capitalization (Millions $) 178
•  Shares Outstanding (Millions) 67
•  Employees 32
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) -49
•  Cash Flow (TTM) (Millions $) 5
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 6.58
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.18
•  Asset Turnover Ratio (TTM) 0.01
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com